Financial news, mergers and acquisitions, partnerships, and alliances.
The firm has ongoing collaborations to use metagenomic sequencing in water treatment facilities and aims to move into the microbiome testing space.
The company's Life Sciences segment was up 17 percent year over year, while its Diagnostics business grew 8 percent.
PerkinElmer will offer providers and patients screening for ASAH1 mutations through its PerkinElmer Genomics laboratory unit.
The company plans to use the funding to build beta units of its optical nanopore sequencer for early adopters in industry and academia.
The firm's CEO Kevin Ness said confirmation of MAD7's editing activity in human HEK293T cells shows the potential for Inscripta's technology.
Sometimes genetic tests give inconclusive results and provide little reassurance to patients, the Associated Press reports.
Vox wonders whether gene-editing crops will be viewed similarly as genetically modified organisms of if people will give them a try.
In Science this week: research regulation and reporting requirement reform, and more.
With H3Africa, Charles Rotimi has been working to bolster the representation of African participants and African researchers in genomics, Newsweek reports.
